Company page
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. is a public company traded under the ticker RARE in the American market. The company has a market capitalization of approximately $2.88 billion. Ultragenyx focuses on developing innovative treatments for rare and ultra-rare genetic diseases.
- Ticker
- RARE:NASDAQ
- Asset type
- Stock
- Market cap
- $2.45B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD